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Prealbumin is as important as albumin in the nutritional assess- tive risk (RR) of death between two- and tenfold or
ment of hemodialysis patients. more, depending on the severity of PEM and the interac-
Background. Although serum prealbumin is considered a tion of PEM with other factors (age, anemia, dialysisvalid indicator of nutritional status in hemodialysis patients,
vintage, etc.) [1–3]. Serum albumin has been the mostthere is relatively little evidence that its determination is of
commonly employed marker of PEM, based largely onmajor prognostic significance. In this study, we aimed to deter-
mine the independent association of serum prealbumin with the statistical association between diminished serum al-
survival in hemodialysis patients, after adjusting for serum al- bumin, mortality, and morbidity. Indeed, the Health Care
bumin and other indicators of protein energy nutritional status.
Financing Administration’s (HCFA) core clinical indica-Methods. Serum prealbumin was measured in more than 1600
tors for adequate dialysis treatment involves an audit ofmaintenance hemodialysis patients. We determined the corre-
lations among prealbumin and other indicators of nutritional serum albumin concentration in dialysis facilities [4] co-
status, including serum albumin, and bioimpedance-derived indi- equal with anemia and measures reflecting the adequacy
cators of body composition. The relationship between serum of dialysis.prealbumin and survival was determined using proportional
The clinical approach to the patient with PEM withinhazards regression.
the dialysis facility is ideally multidisciplinary, withResults. The serum albumin was directly correlated with the
serum prealbumin (r 5 0.47, P , 0.0001), but still explained nephrologist and renal dietitian collaborating to address
,25% of the variability in prealbumin. Prealbumin was in- the patient’s underlying remediable medical conditions
versely related to mortality, with a relative risk reduction of as well as ensuring that dietary intake is adequate to6% per 1 mg/dL increase in prealbumin, even after adjusting
meet metabolic needs. Identification of patients at riskfor case mix, serum albumin, and other nutritional indicators.
The increase in risk with lower serum prealbumin concentra- is an essential part of quality care attempting to abrogate
tions was observed whether the serum albumin was high or low. the burden of PEM in the maintenance dialysis popula-
Conclusion. In hemodialysis patients, the serum prealbumin tion. However, a thorough understanding of the underly-
provides prognostic value independent of the serum albumin
ing pathophysiology(s) of PEM in dialysis patients isand other established predictors of mortality in this population.
lacking, including the relative contributions of dietary
intake and inflammation. There is no uniform agreement
about appropriate therapy for this condition. An im-Protein energy malnutrition (PEM) affects more than
proved understanding of the cause(s) and consequences50% of maintenance dialysis patients and is unequivo-
of PEM is required to enhance quality of care for dialysiscally associated with morbidity and mortality. Whether
patients. Such an understanding necessarily includes arelated to diminished dietary intake, inflammation, ade-
thorough understanding of the markers of PEM andquacy of dialysis, socioeconomic factors, or a combina-
their prognostic significance.tion thereof, patients with evidence of PEM have a rela-
As part of the National Kidney Foundation Dialysis
Outcomes Quality Initiative (NKF-DOQI) Practice Guide-
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line on Nutrition, the validity and clinical utility of severalalbumin, mortality and hemodialysis, chronic renal disease, adequacy
of dialysis, dietary metabolic needs. indicators of PEM, including prealbumin (also known
as transthyretin), were subject to a thorough, evidence-Received for publication April 7, 2000
based literature review [5]. Prealbumin was deemed aand in revised form June 6, 2000
Accepted for publication June 9, 2000 valid and clinically useful indicator of PEM in mainte-
nance dialysis patients by the NKF-DOQI panel. How-Ó 2000 by the International Society of Nephrology
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ever, the quantity of evidence linking prealbumin to Statistical analysis
PEM and to morbidity and mortality was small relative Continuous variables were expressed as mean 6 SD
to the evidence for other biochemical markers, such as and compared with Student’s t-test, the Wilcoxon rank
serum albumin and creatinine [6–10]. There were several sum test, or analysis of variance (ANOVA) where appro-
important questions regarding prealbumin that remained priate. Correlation among variables was described with
unanswered. First, the goal serum prealbumin concentra- the Pearson product moment correlation coefficient.
tion was unknown. Published reports had stratified pa- Categorical variables were described using proportions
tients above and below 30 mg/dL, a value well within and were analyzed with the x2 test. Prealbumin was ana-
the normal range for nonuremic adults [6–10]. Second, lyzed as a continuous variable and in categories deter-
since prealbumin concentration is partly dependent on mined a priori of 5 mg/dL increments (,20, 20 to 25, 25 to
glomerular filtration, there was concern that confound- 30, 30 to 35, .35 mg/dL). Unadjusted and multivariable
ing by renal function would limit its specificity, particu- analyses [adjusted for age, gender, race or ethnicity, dia-
larly among incident dialysis patients with residual renal betes, vintage (time since initiation of dialysis), albumin,
function. Finally, while some investigators had suggested creatinine, dialysis dose, hemoglobin, ferritin, body size,
that prealbumin might be superior to albumin as an indi- and phase angle] were conducted to explore the associa-
tion between prealbumin concentration and survival.vidual predictor of mortality in dialysis, it was not known
Multivariable regression was performed using the pro-whether there was marginal predictive power once serum
portional hazards (“Cox”) model, with variable entryalbumin was accounted for, and if so, whether the added
and exit criteria set at the P 5 0.05 level [12]. Plots ofvalue of prealbumin was restricted to patients with high
log [2log (survival rate)] against log (survival time) wereor low serum albumin concentrations. We therefore un-
performed to establish the validity of the proportionalitydertook the following analyses in an effort to answer
assumption [13]. Multiplicative interaction terms werethese inquiries.
tested to explore interaction among prealbumin concen-
tration and selected explanatory variables. An indicator
METHODS variable for “missing” prealbumin was included in all
Study subjects regression models. Stratified analyses were conducted
among subjects below and above the median serum albu-Study subjects were 3009 prevalent adult hemodialysis
min concentration to determine whether the associationpatients from 101 free-standing Fresenius Medical Care
between prealbumin and survival was albumin depen-North America (FMCNA) dialysis units across the United
dent. Unadjusted and multivariable RRs and 95% con-States. Inclusion criteria included age $18 years and
fidence intervals (95% CI) were calculated based onthree times weekly in-center hemodialysis for $3 months.
model parameter coefficients and standard errors, re-Patients with an amputation above the transmetatarsal
spectively. Patients who underwent kidney transplanta-site were excluded from participation. Bioelectrical im-
tion (N 5 82, 2.7%), recovered renal function (N 5 18,pedance analysis (BIA Quantum; RJL Systems, Inc.,
0.6%), transferred dialysis facilities (N 5 287, 9.7%),Clinton Twp., MI, USA) was performed before a mid-
withdrew from dialysis (N 5 42, 1.3%), or were lostweek dialysis session during the first six months of 1995.
to follow-up for unknown reasons (N 5 8, 0.3%) wereWeight was obtained before dialysis. Details of the BIA
censored. Subjects with and without prealbumin valuesexamination are provided elsewhere [11]. Resistance and
were compared to evaluate whether missing data for thisreactance in ohms was obtained directly from the BIA
variable were missing roughly at random. Two-taileddevice. Phase angle was calculated in radians and multi-
P values of less than 0.05 were considered statisticallyplied by 180/p (,3.14159265) to covert radians to degrees.
significant. Statistical analyses were conducted usingReactance, resistance, phase angle, and the derived esti-
SAS 6.12 (SAS Institute, Cary, NC, USA).
mates of total body water (TBW) and body cell mass
(BCM) were merged with the Patient Statistical Profile,
RESULTSa database with selected demographic, historic, and labo-
ratory information on patients cared for at FMCNA- The mean age was 60.5 6 15.5 years; the demographics
affiliated dialysis facilities. Laboratory values were means were 47.2% of the patients were women, 46.9% were
of the three months proceeding BIA testing. Serum albu- black, 45.4% were white, 6.5% were Hispanic, 1.2% were
min was measured using the bromocresol green method. of another race or ethnicity, and 36.5% had diabetes.
Serum prealbumin was measured using immunopreci- Table 1 shows the baseline demographic, laboratory, and
pitin analysis. The duration of follow-up after BIA test- body composition (by BIA) characteristics of patients
ing ranged from 2 days to 18 months. Patients whose with (N 5 1618, 54%) and without (N 5 1372, 46%)
survival time was unknown or uninterpretable (N 5 19, serum prealbumin values. Fewer African Americans and
more Caucasians were tested (P , 0.0001). The mean0.6%) were excluded from the analysis.
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Table 2. Patient characteristics by prealbumin categoryTable 1. Demographic, laboratory, and body composition data on
patients with and without prealbumin measurements
,20 20–25 25–30 30–35 .35 P value
Prealbumin 1 Prealbumin 2 P value
Age year 65.1 62.4 61.0 58.1 55.0 ,0.0001
Sex % female 50.6 51.7 45.7 41.3 35.0 0.002Age year 60.8615.2 60.0615.7 0.16
Sex % female 46.8% 48.5% 0.16 Race or ethnicity 0.001
Caucasian 64.6 52.7 45.3 40.7 29.3Race or ethnicity ,0.0001
Caucasian 47.5% 43.0% African American 31.7 38.9 43.0 50.7 57.1
Hispanic 2.9 7.6 10.4 7.7 10.7African American 43.2% 51.2%
Hispanic 8.1% 4.6% Other 0.8 0.8 1.4 0.9 2.9
Diabetes % 46.4 39.4 35.5 27.4 27.9 0.001Other 1.2% 1.2%
Diabetes % 35.7% 37.5% 0.29 Vintage year 3.79 3.90 3.94 3.93 3.70 0.96
Height cm 166.2 165.9 166.8 168.2 168.4 0.03Vintage years 3.963.6 3.863.8 0.32
Height cm 166.9611.4 167.0611.1 0.91 Weight kg 70.0 72.9 75.1 75.3 79.7 ,0.0001
Creatinine mg/dL 8.3 10.0 10.9 12.2 13.4 ,0.0001Weight kg 74.3618.6 74.3618.5 0.94
Creatinine mg/dL 10.863.6 10.963.5 0.72 BUN mg/dL 58.5 64.8 68.6 73.6 79.2 ,0.0001
Albumin g/dL 3.57 3.77 3.89 4.00 4.13 ,0.0001Pre-dialysis BUN
mg/dL 68.2617.1 67.2617.4 0.11 Cholesterol mg/dL 151.8 169.8 178.2 186.9 195.2 ,0.0001
Bicarbonate mEq/L 20.8 20.4 20.1 20.0 19.3 ,0.0001Albumin g/dL 3.8660.36 3.8460.36 0.27
Cholesterol mg/dL 175.7646.6 177.0644.3 0.44 Hemoglobin g/dL 10.1 10.1 10.5 10.6 10.6 ,0.0001
Ferritin mg/L 418 416 433 446 530 0.16Bicarbonate mEq/L 20.262.8 20.662.9 0.0003
Hemoglobin g/dL 10.461.1 10.261.1 ,0.0001 URR % 64.3 65.6 65.4 65.8 65.2 0.13
Kt/V 1.05 1.09 1.08 1.09 1.07 0.23Ferritin lg/L 290 (143 to 591) 242 (108 to 470) ,0.0001
URR % 65.467.1 65.466.9 0.99 Kt L 41.1 42.8 43.1 44.4 45.8 ,0.0001
Resistance X 505.4 494.8 502.1 500.9 473.6 ,0.0001Kt/V 1.0860.21 1.0860.21 0.93
Kt L 43.369.8 43.369.3 0.96 Reactance X 34.5 37.2 40.2 43.9 46.6 ,0.0001
Phase angle degrees 4.07 4.41 4.67 5.13 5.79 ,0.0001Resistance X 498.2694.4 497.26100.1 0.79
Reactance X 40.0613.7 41.9613.8 0.0002 TBW kg 39.7 40.2 40.7 41.5 43.6 0.0007
BCM kg 24.4 25.1 25.8 27.2 28.4 ,0.0001Phase angle degrees 4.7161.74 4.9461.79 0.0004
TBW kg 40.869.4 40.869.1 0.83 Abbreviations are: BUN, blood urea nitrogen; URR, urea reduction ratio;
BCM kg 26.065.8 26.365.8 0.17 TBW, total body water estimated by BIA; BCM, body cell mass estimated by
BIA. N 5 237, 383, 519, 339, and 140 in ,20, 20–25, 25–30, 30–35, $35 mg/dLAbbreviations are: BUN, blood urea nitrogen; URR, urea reduction ratio;
groups. The P value refers to overall analysis of variance (ANOVA).TBW, total body water estimated by BIA; BCM, body cell mass estimated by
BIA. N 5 1618 and 1372 in prealbumin 1 and prealbumin 2 groups, respectively.
Prealbumin was categorized a priori into the following
hemoglobin and serum ferritin values were slightly five groups: ,20, 20 to 25, 25 to 30, 30 to 35, and $35
higher, and the bicarbonate, reactance, and phase angle mg/dL (corresponding to 14.6, 23.7, 32.1, 21.0, and 8.7%
by BIA values were slightly lower in the group whose of the tested population). Table 2 displays patient charac-
prealbumin was tested. These differences persisted after teristics within the five prealbumin categories. It is note-
adjusting for the imbalance in race or ethnicity. Overall, worthy that women, Caucasians, and persons with diabe-
there were few statistically significant or clinically mean- tes were underrepresented in the higher prealbumin
ingful differences in the tested and nontested groups, categories. Indeed, the prealbumin concentration was
indicating little overt bias in prealbumin test ordering. significantly lower among women (26.0 vs. 27.2 mg/dL
In other words, prealbumin was not ordered exclusively
in men, P 5 0.0002), Caucasians (25.4 vs. 27.9 mg/dL in
in subjects with low serum albumin or other nutritional
nonwhites, P , 0.0001), and persons with diabetes (25.5
or related disorders.
vs. 27.3 mg/dL in persons without diabetes, P , 0.0001).The mean serum prealbumin was 26.6 6 6.4 mg/dL
(median 26.8, interquartile range 22.6 to 30.9, full range Prealbumin and mortality
2.8 to 52.3 mg/dL) and was normally distributed (Wilk-
The unadjusted RR of death was 0.91 (95% CI, 0.90Shapiro x2, P 5 0.97). Prealbumin was directly correlated
to 0.93) per mg/dL increase in prealbumin concentration.with all nutritional indicators, including serum albumin
In other words, there was a 9% decrease in the risk of(r 5 0.47), creatinine (r 5 0.42), predialysis blood urea
death for each 1 mg/dL increase in the serum prealbuminnitrogen (r 5 0.34), cholesterol (r 5 0.26), predialysis
concentration. The RR of death was attenuated slightlybody weight (r 5 0.13), reactance (r 5 0.27), phase angle
(RR 0.92, 95% CI 0.90 to 0.94) after adjustment for case(r 5 0.27), TBW (r 5 0.10), and BCM (r 5 0.20), and
mix (that is, age, gender, race, diabetes, vintage). Eveninversely correlated with age (r 5 20.18, P , 0.0001 for
after forcing serum albumin, creatinine, hemoglobin, fer-all Pearson r values). While the correlation with serum
ritin, phase angle, Kt (or URR and URR2), and bodyalbumin was relatively high, it was far from 1.0. Indeed,
weight (or Quete´let’s index or TBW) into the model,with a correlation of 0.47, less than one fourth of the
the association between serum prealbumin and mortalityvariability in serum prealbumin can be explained by the
serum albumin concentration. remained statistically significant (RR 0.94, 95% CI, 0.92
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Table 3. Unadjusted, case mix-adjusted, and multivariable-adjusted RR (and 95% CI) of death by prealbumin category
Prealbumin Unadjusted Case-mix adjusted Multivariable-adjusted
,20 mg/dL 4.42 (2.81 to 6.97) 3.43 (2.17 to 5.43) 2.58 (1.59 to 4.16)
20–25 mg/dL 2.03 (1.27 to 3.24) 1.71 (1.07 to 2.73) 1.51 (0.94 to 2.44)
25–30 mg/dL 1.14 (0.70 to 1.85) 1.00 (0.62 to 1.63) 0.95 (0.59 to 1.55)
30–35 mg/dL 1.00 1.00 1.00
$35 mg/dL 0.77 (0.35 to 1.70) 0.90 (0.41 to 2.00) 0.98 (0.47 to 2.16)
N 5 237, 383, 519, 339, and 140 in ,20, 20–25, 25–30, 30–35, and $35 mg/dL groups. Relative rate (RR) and 95% CI are derived from proportional hazards
regression analysis using the 30–35 mg/dL group as the referent.
to 0.96). The designation of “missing” prealbumin values patients with prealbumin ,15, 15 to 20, and 20 to 25 mg/dL
was not associated with death risk (P 5 0.55). were all significantly increased (RR 2.80, 95% CI 1.62
Serum albumin and prealbumin were placed into mod- to 4.82, RR 2.48, 95% CI 1.70 to 3.62, and RR 1.53, 95%
els together to compare their relative predictive power. In CI 1.07 to 2.17).
unadjusted, case mix-adjusted, and multivariable-adjusted To evaluate whether prealbumin was less specific as
models, including only those patients with prealbumin a nutritional indicator among patients with residual renal
values, the x2 associated with the prealbumin term was function, we stratified patients by vintage (above and
higher, indicating explanation of a larger fraction of the below the median of 2.6 years), assuming that residual
variance (unadjusted x2 39.6 vs. 5.1, case mix adjusted renal function would be negligible in most patients after
x2 26.2 vs. 2.8, multivariable adjusted x2 22.5 vs. 1.9, pre- this time. Unadjusted, case mix-adjusted, and multivari-
albumin vs. albumin). In the latter two instances, serum able-adjusted RRs for serum prealbumin were significant
albumin lost its conventional statistical significance with in both subgroups (data not shown), suggesting that the
inclusion of the prealbumin term. effect of prealbumin was not excessively confounded by
Since serum albumin and prealbumin are both reflec- residual renal function.
tive of the visceral protein pool and acute phase re-
actants, we explored whether the prealbumin-mortality
DISCUSSIONrelationship was dependent on albumin. In other words,
These studies confirm that serum albumin and preal-we inquired whether the association between prealbumin
bumin are directly correlated, but that each explainsand mortality was restricted to individuals with low or
,25% of the concentration of the other. Furthermore,high serum albumin concentrations. Indeed, the associa-
these studies suggest that the serum prealbumin concen-tion between prealbumin and mortality was not depen-
tration may be more closely associated with mortalitydent on the albumin concentration. The RRs of death
than serum albumin, the current standard indicator ofper 1 mg/dL increase in prealbumin were 0.92 and 0.93
PEM [4, 14]. Based on these findings, one might askin patients with serum albumin concentrations above and
whether prealbumin should be used as the standard,below the median, respectively. Moreover, the relation-
rather than albumin. More reasonably, both seem toship between prealbumin and mortality was not influ-
provide complementary information regarding PEM,enced by age, gender, race, diabetes, or vintage (multipli-
just as serum albumin and creatinine concentrations do.cative interaction term P values, 0.11 to 0.73).
In any case, it has become clear that a more in-depthTo test the linearity assumptions applied previously
understanding of the cause(s) of and potential therapiesin this article, we evaluated the serum prealbumin con-
for PEM in dialysis patients will be required in order tocentration in five categories: ,20, 20 to 25, 25 to 30, 30
improve clinical outcomes. Such investigations wouldto 35, and $35 mg/dL. These categories were chosen to
seem the responsibility of institutional providers, aca-provide sufficient power within categories to assess risk
demic medical centers, and governments, rather thanrelative to the “goal” prealbumin concentration (.30
dialysis facilities per se.mg/dL) proposed by Avram et al [6–9]. The unadjusted,
Prealbumin, also known as transthyretin, is a 54,000 Dcase mix-adjusted, and multivariable-adjusted RRs and
protein synthesized primarily by the liver. Its main func-95% CIs for each prealbumin category (relative to 30 to
tion is to transport thyroxine and indirectly vitamin A,35 mg/dL) are listed in Table 3. Since the serum albumin
as it serves as a carrier protein for retinol binding proteinand prealbumin concentrations were directly correlated,
[15]. In humans, prealbumin has been shown to increaseadjustment for serum albumin in multivariable regres-
with increases in protein and calorie intake and to de-sion models sharply reduced the significance level for
crease when protein intake is inadequate [15]. As witheach prealbumin category relative to the referent cate-
serum albumin, prealbumin has been shown to decreasegory. If one considered a prealbumin “cut-off” of 25 mg/dL
rather than 30 mg/dL, the multivariable RR of death for in the face of acute or chronic inflammation (that is,
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“acute phase reactant”), limiting its specificity as a marker sample size was relatively small so that the power to
explore potential interactions among prealbumin, demo-of nutritional intake. In contrast to serum albumin, how-
ever, its half-life is relatively short (,2 to 3 days). It has graphic factors, and indicators of nutritional status was
limited.therefore been suggested that prealbumin may be a more
sensitive indicator of nutritional status than either serum In summary, serum prealbumin was normally distrib-
uted in more than 1600 maintenance hemodialysis pa-albumin or transferrin [16].
Much of the clinical research linking serum prealbu- tients, with a mean value of 26.6 mg/dL. As with serum
albumin, values well within the reference range (18.0min to mortality in dialysis patients has been performed
by Avram et al [6–9]. In their most recent report, Sreed- to 33.8 mg/dL; Lifechem Laboratories, Rockleigh, NJ,
USA) were associated with a significantly increased riskhara et al found that a serum prealbumin ,30 mg/dL at
the initiation of dialysis was associated with an increased of death. The serum prealbumin stratified mortal risk at
least as well as serum albumin when both variables wererisk of death in 111 hemodialysis (RR 5 2.6, P 5 0.002)
and 78 peritoneal dialysis patients (RR 5 1.8, P 5 0.035) included simultaneously in multiple regression models.
There was a graded change in the RR of death (multivari-followed over five years. The association between preal-
bumin and mortality remained significant in the larger able linear estimate 6% increase in risk per 1 mg/dL
decrease in prealbumin) by prealbumin concentration.hemodialysis group after adjusting for the effects of age
and diabetes in a multivariable model. It is noteworthy The risk of death was unambiguously increased among
individuals with serum prealbumin ,25 mg/dL, eventhat Sreedhara et al found that inclusion of prealbumin
in the mortality model extinguished the significance of after adjusting for serum albumin, case mix, and other
established predictors of death in hemodialysis patients.the serum albumin term, as we have also confirmed.
These investigators and others [17] have shown the cor- While there was insufficient power to demonstrate a
significant difference among the 25 to 30 mg/dL, 30 torelation between serum albumin and prealbumin to be
in the range of r 5 0.5. 35 mg/dL, and .35 mg/dL groups (in part because of
collinearity between albumin and prealbumin), there isTwo small studies have examined the effects of nutri-
tion support on serum prealbumin values. Vehe et al reason to believe that higher values would be associated
provided nutrition support (,34 kcal/kg/day and 1.3 g with lower risk, based on the unadjusted analyses and
protein/kg/day) to 14 patients with chronic renal failure linear trends presented here. While any recommenda-
and examined the change in serum levels of insulin growth tions for the routine use of prealbumin must take into
factor-1 (IGF-1), fibronectin, and prealbumin from base- account the costs of laboratory testing along with the
line at seven and 28 days [18]. Prealbumin increased likelihood of affecting change after identification of an
significantly from 15.3 6 7.8 to 24.6 6 19.0 mg/dL by abnormality, these data answer some of the questions
day 28 (P , 0.01). Cumulative nonprotein calories (r 5 (vide supra) regarding the validity of serum prealbumin
0.37, P , 0.01) and cumulative protein intake (r 5 0.43, (transthyretin) in hemodialysis patients and provide
P , 0.01) were directly correlated with serum prealbu- compelling evidence for its providing added value in
min. More recently, Mortelmans et al showed a nonsig- nutritional assessment. Longitudinal analyses exploring
nificant increase in serum prealbumin in 16 patients given the specificity of prealbumin for PEM, its sensitivity to
intradialytic parenteral nutrition over a nine-month pe- change, and its performance relative to albumin and
riod [19]. Larger studies are clearly needed to determine other serum proteins will be necessary to define better
whether prealbumin is a suitable parameter to follow its role in nutritional (and inflammatory) assessment and
after initiation of nutrition support. therapy in end-stage renal disease.
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